Brevets délivrés |
Date d’expiration (à l’exclusion des SPC) |
|||
| Brevet | Titre | Pays | Exp. Date | |
| WO2004/024189 | Stable immunogenic product comprising antigenic heterocomplexes | Composition of matter | EP, US, CN,CA, ZA, AU, BR, JP, IN, NZ | 2023 |
| WO2005/028513 | High yield method for the production of human antibodies blocking the biological activity of a human cytokine |
Composition of matter | EP, US, CA, JP | 2024 |
| WO2012/136739 | Method for treating IFNα related conditions | Use/method | EP, US, HK, AU, BR, MX, RU, JP, CN, IL, IN, KR, CA | 2032 |
Brevets en cours de procédure |
||||
| WO2019/229153 | Immunogenic product comprising IL4 and/or IL13 for treating disorders associated with aberrant IL4 and/or IL13 expression or activity | Composition of matter | EP, US, HK, US, AU, BR, CA, CN, CU, IL, IN, JP, KR, MX, NZ, RU, SG, ZA | 2039 |
| WO2022/058571 | Immunogenic product comprising an IgE fragment for treating IgE-mediated inflammatory disorders | Composition of matter | PCT | 2041 |
| PCT | mRNA vaccines comprising IL-4 and/or IL-13 RNA and uses thereof | Composition of matter | PCT | 2042 |